M. Ross Johnson
Director/Board Member at Nuada Pharmaceuticals, Inc.
M. Ross Johnson active positions
| Companies | Position | Start | End |
|---|---|---|---|
Nuada Pharmaceuticals, Inc.
 Nuada Pharmaceuticals, Inc. Pharmaceuticals: MajorHealth Technology Nuada Pharmaceuticals, Inc. operates as a pharmaceutical company. The private company is based in Durham, NC. | Director/Board Member | - | - |
| The University of North Carolina at Charlotte | Corporate Officer/Principal | 15/06/2011 | - |
Career history of M. Ross Johnson
Former positions of M. Ross Johnson
| Companies | Position | Start | End |
|---|---|---|---|
| RESPIRERX PHARMACEUTICALS INC. | Director/Board Member | 31/03/2002 | 21/03/2013 |
| Independent Dir/Board Member | 21/06/2011 | 21/03/2013 | |
Mast Therapeutics, Inc.
 Mast Therapeutics, Inc. Pharmaceuticals: MajorHealth Technology Mast Therapeutics, Inc. is a biopharmaceutical company, which engages in developing novel therapies for serious or life-threatening diseases with significant unmet needs. It leveraging Molecular Adhesion and Sealant Technology, platform, derived from over two decades of clinical, nonclinical, and manufacturing experience with purified and non-purified poloxamers to develop vepoloxamer, which also known as MST-188. The company was founded by Warren C. Lau in December 1995 and is headquartered in San Diego, CA. | Chairman | 30/09/2002 | 05/03/2007 |
Trimeris, Inc.
 Trimeris, Inc. Pharmaceuticals: MajorHealth Technology Trimeris, Inc. develops therapeutics for viral diseases. It is a biopharmaceutical company engaged in the discovery, development and commercialization of novel therapeutic agents for the treatment of viral disease. The core technology platform of fusion inhibition is based on blocking viral entry into host cells. The company was founded in 1993 and is headquartered in Durham, NC. | Chief Tech/Sci/R&D Officer | 31/12/1994 | 31/12/1998 |
| President | 31/12/1994 | 31/12/1998 | |
| Glaxo, Inc. | Corporate Officer/Principal | 31/12/1986 | 31/12/1993 |
| PFIZER, INC. | Corporate Officer/Principal | - | - |
Research Triangle Institute
 Research Triangle Institute Miscellaneous Commercial ServicesCommercial Services Research Triangle Institute is a non-profit organization which provides research and development services. It offers surveys and data collection, statistics and data science, assessment and analysis, program design and implementation, and research technologies and analytical laboratory. The company was founded in 1958 and is headquartered in Research Triangle Park, NC. | Director/Board Member | - | - |
Training of M. Ross Johnson
| University of California, Berkeley | Undergraduate Degree |
| University of California, Santa Barbara | Doctorate Degree |
Statistics
International
| United States | 10 |
| Canada | 2 |
Operational
| Director/Board Member | 3 |
| Corporate Officer/Principal | 3 |
| Independent Dir/Board Member | 1 |
Sectoral
| Health Technology | 6 |
| Consumer Services | 4 |
| Commercial Services | 2 |
Positions held
Active
Inactive
Listed companies
Private companies
Linked companies
| Listed companies | 2 |
|---|---|
| RESPIRERX PHARMACEUTICALS INC. | Health Technology |
| PFIZER, INC. | Health Technology |
| Private companies | 5 |
|---|---|
Mast Therapeutics, Inc.
Mast Therapeutics, Inc. Pharmaceuticals: MajorHealth Technology Mast Therapeutics, Inc. is a biopharmaceutical company, which engages in developing novel therapies for serious or life-threatening diseases with significant unmet needs. It leveraging Molecular Adhesion and Sealant Technology, platform, derived from over two decades of clinical, nonclinical, and manufacturing experience with purified and non-purified poloxamers to develop vepoloxamer, which also known as MST-188. The company was founded by Warren C. Lau in December 1995 and is headquartered in San Diego, CA. | Health Technology |
Trimeris, Inc.
Trimeris, Inc. Pharmaceuticals: MajorHealth Technology Trimeris, Inc. develops therapeutics for viral diseases. It is a biopharmaceutical company engaged in the discovery, development and commercialization of novel therapeutic agents for the treatment of viral disease. The core technology platform of fusion inhibition is based on blocking viral entry into host cells. The company was founded in 1993 and is headquartered in Durham, NC. | Health Technology |
| Glaxo, Inc. | |
Research Triangle Institute
Research Triangle Institute Miscellaneous Commercial ServicesCommercial Services Research Triangle Institute is a non-profit organization which provides research and development services. It offers surveys and data collection, statistics and data science, assessment and analysis, program design and implementation, and research technologies and analytical laboratory. The company was founded in 1958 and is headquartered in Research Triangle Park, NC. | Commercial Services |
Nuada Pharmaceuticals, Inc.
Nuada Pharmaceuticals, Inc. Pharmaceuticals: MajorHealth Technology Nuada Pharmaceuticals, Inc. operates as a pharmaceutical company. The private company is based in Durham, NC. | Health Technology |
- Stock Market
- Insiders
- M. Ross Johnson
- Experience
